Biomics

The coronavirus pandemic led to increased interest toward using the biologically active components of Scutellaria baicalensis Georgi. However, the unauthorized harvesting of plants in their natural habitat has indicated potential threats to the floral biodiversity. Therefore, in vitro cultivation of plant cells becomes particularly relevant. That approach provides an opportunity to work with plant material without damaging the environment and regardless of the season and climatic conditions. Culturing plant cells under controlled conditions is a sensitive process depending on internal and external factors. In order to reduce the probability of deterioration of quantitative and qualitative indicators of the biomass, we suggest a risk assessment strategy.

plant cell cultivation, suspension cultures, secondary metabolites, critical points, acceptable risk level, culture protection, risk assessment strategy

1. Cascella M. et al. Features, evaluation and treatment coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. URL: https://www.ncbi.nlm.nih.gov/books/NBK554776/

2. Guerriero G. et al. Production of plant secondary metabolites: examples, tips and suggestions for biotechnologists. Genes (Basel). 2018. V.9. P. 309. DOI: 10.3390/genes9060309

3. Eibl R. et al. Plant cell culture technology in the cosmetics and food industries: Current state and future trends. Appl. Microbiol. Biotechnol. 2018. V. 102. P. 8661–8675. DOI: 10.1007/s00253-018-9279-8

4. Kharchenko E.P. Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors. Epidemiology and Vaccinal Prevention. 2020. V.19(5). P.4-17. (In Russian) DOI: 10.31631/2073-3046-2020-19-5-4-17

5. Kharchenko E.P. The Coronavirus SARS-Cov-2: the Complexity of Infection Pathogenesis, the Search of Vaccines and Possible Future Pandemics. Epidemiology and Vaccinal Prevention. 2020. V.19(3). P.4-20. (In Russian) DOI: 10.31631/2073-3046-2020-19-3-4-20

6. Kumar R. et al. The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic. Curr Med Chem. 2021. V.28(15). P.2852-2886. doi: 10.2174/0929867327666200702151018

7. Liu H. et al. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. Journal of Enzyme Inhibition and Medicinal Chemistry. 2021. V. 36(1). P. 497-503. DOI: 10.1080/14756366.2021.1873977

8. Motolinia-Alcantara E.A. et al. Engineering considerations to produce bioactive compounds from plant cell suspension culture in bioreactors. Plants. 2021. V.10(12). P. 2762. DOI: 10.3390/plants10122762

9. Narayani M. et al. A stimulation of stress in in vitro plant cell/tissue cultures for enhancement of secondary metabolite production. Phytochem. Rev. 2017. V.16. P. 1227–1252. DOI: 10.1007/s11101-017-9534-0

10. Niazian M. Application of genetics and biotechnology for improving medicinal plants. Planta. 2019. V. 249. P. 953–973. DOI:
10.1007/s00425-019-03099-1

11. Patel A., Jernigan D.B. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak ‐ United States, December 31, 2019 - February 4, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020. V.69(5). P. 140–146. DOI: 10.15585/mmwr.mm6905e1

12. Pei T. et al. Specific Flavonoids and Their Biosynthetic Pathway in Scutellaria baicalensis. Frontiers in Plant Science. 2022. V. 13. P. 866282. DOI: 10.3389/fpls.2022.866282

13. Remali J., Aizat W.M. A review on plant bioactive compounds and their modes of action against coronavirus infection. Front. Pharmacol. 2021. V.11. P. 589044. DOI: 10.3389/fphar.2020.589044

14. Tay M.Z. et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 2020. V.20(6). P. 363–374. DOI: 10.1038/s41577-020-0311-8

15. Xiang L. et al. Therapeutic potential of Scutellaria baicalensis Georgi in lung cancer therapy. Phytomedicine. 2022. V.95. 2021. P. 153727. DOI: 10.1016/j.phymed.2021.153727